University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Public-Private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One

Public-Private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One

October 26, 2017

Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and UCSF will combine vast data stores, supercomputing, and scientific expertise to reinvent the discovery process for cancer medicines.

UCSF's Cryo-Electron Microscopy Advancements Bring Atomic-Level Life into Clearer View

UCSF's Cryo-Electron Microscopy Advancements Bring Atomic-Level Life into Clearer View

October 26, 2017

UC San Francisco researchers recently captured exquisite images of a protein caught in the act of binding to a novel therapeutic drug with enough resolution to model how the individual atoms of the protein and drug lined up. Until recently, such a feat would have ...
Big Data Shows How Cancer Interacts with Its Surroundings

Big Data Shows How Cancer Interacts with Its Surroundings

October 20, 2017

By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal ...
Researchers to Combat Drug-Resistant Lung Cancer at New NCI-Funded Center at UCSF

Researchers to Combat Drug-Resistant Lung Cancer at New NCI-Funded Center at UCSF

October 19, 2017

The National Cancer Institute (NCI) has announced that UC San Francisco will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016.    The center, a collaboration with ...
Renowned Cancer Virologists to Deliver Annual Sokolow Lectureship

Renowned Cancer Virologists to Deliver Annual Sokolow Lectureship

October 12, 2017

Two of the sharpest minds in the field of cancer virology are scheduled to present the Maurice, Ethel, and Jane Sokolow Memorial Cancer Endowment Lectureship at the HDFCCC on October 25th and 26th. Yuan Chang, MD, and Patrick S. Moore, MD, MPH, from the University ...
Hard-Core Smokers are Softening Over Time

Hard-Core Smokers are Softening Over Time

October 10, 2017

Cigarette smokers with high levels of psychological distress are often heavy smokers, and thus identified as a “hard core” group who are less willing or able to quit than other smokers. However, a study by UC San Francisco researchers shows that over the course of ...
Two UCSF Scientists Win NIH New Innovator Awards

Two UCSF Scientists Win NIH New Innovator Awards

October 5, 2017

The National Institutes of Health (NIH) has awarded grants to two UC San Francisco researchers to pursue innovative approaches to major contemporary challenges in biomedical research. The highly competitive grants, which were announced Oct. 5 among 86 such awards nationwide, were made under the High-Risk, High-Reward Research ...
Susan G. Komen® Recognizes Renowned Investigators as 2017 Recipients of Brinker Awards for Scientific Distinction

Susan G. Komen® Recognizes Renowned Investigators as 2017 Recipients of Brinker Awards for Scientific Distinction

October 5, 2017

Today two widely respected and accomplished breast cancer investigators join the ranks of an esteemed group of scientists as recipients of this year’s Brinker Awards – the highest scientific honor awarded by Susan G. Komen, the world’s leading breast cancer organization.   Established by Komen ...
Strata Oncology, Inc. Announces Partnership with UCSF to Launch StratifyProstateTM Initiative to Expand Access to Precision Medicine Clinical Trials for 10,000 Men with Metastatic Prostate Cancer

Strata Oncology, Inc. Announces Partnership with UCSF to Launch StratifyProstateTM Initiative to Expand Access to Precision Medicine Clinical Trials for 10,000 Men with Metastatic Prostate Cancer

October 3, 2017

Strata Oncology, Inc. (Strata), a precision oncology company, announced a collaboration with the University of California San Francisco (UCSF) to launch StratifyProstateTM a unique initiative focused on expanding access to tumor sequencing nationwide for men with advanced prostate cancer and to dramatically accelerate enrollment into ...
UCSF First in State to Provide FDA-Approved CAR-T for Pediatric Cancer Patients

UCSF First in State to Provide FDA-Approved CAR-T for Pediatric Cancer Patients

September 18, 2017

UCSF Benioff Children’s Hospital San Francisco has been certified as the first medical center in California to provide CAR-T therapy for children and young adults with acute lymphoblastic leukemia (ALL), who have failed standard treatment.